Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SR 27417

Known as: SR-27417, SR27417A 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Platelet-activating-factor receptor (PAFR) responds to platelet-activating factor (PAF), a phospholipid mediator of cell-to-cell… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2001
2001
Distintas evidencias sugieren que el factor de activacion plaquetaria (PAF)y el oxido nitrico (NO) estarian involucradas en la… Expand
Is this relevant?
1998
1998
BACKGROUND & AIMS Platelet-activating factor (PAF) is increased during relapse of ulcerative colitis. In animal models of… Expand
Is this relevant?
1998
1998
The level of calcitonin gene related peptide (CGRP) in plasma and pulmonary lavage fluid was tested by radio-immunoassay on… Expand
Is this relevant?
1997
1997
Platelet-activating factor (PAF) is a lipid-derived mediator that has been implicated in the pathophysiology of airway… Expand
Is this relevant?
1997
1997
SR 27417, a potent PAF receptor antagonist, inhibited in a dose-dependent manner the hypotensive effect of PAF in rats. It… Expand
Is this relevant?
1995
1995
We examined the effect of platelet-activating factor (PAF) on gastric acid secretion by isolated rabbit gastric glands as… Expand
Is this relevant?
1994
1994
Effect of three specific PAF antagonists, SR-27417, BN-50739 and ginkgolide derivative BN-52021 have been evaluated in models of… Expand
Is this relevant?
1991
1991
In anaphylactic shock, SR 27417, the first member of a newly developed series of PAF (platelet-activating factor) antagonists… Expand
Is this relevant?
1991
1991
SR 27417 [N-(2-dimethylamino ethyl)-N-(3-pyridinyl methyl)[4- (2,4,6-triisopropylphenyl) thiazol-2-yl]amine] is the first member… Expand
Is this relevant?